Previous studies have shown that the chemical hormone corticosteroid, which is released into the body's blood as a stress response, is found at levels two to three times higher in Alzheimer's patients than non-Alzheimer's patients.
"Stress is an environmental factor that looks like it may play a very important role in the onset of Alzheimer's disease," said Domenico Pratico, professor of pharmacology and microbiology and immunology in Temple's School of Medicine in US, who led the study.
The researchers set up a series of experiments to examine the mechanisms by which stress can be responsible for the Alzheimer's pathology in the brain.
Using triple transgenic mice, which develop amyloid beta and the tau protein, two major brain lesion signatures for Alzheimer's, the researchers injected one group with high levels of corticosteroid each day for a week in order to mimic stress.
More From This Section
While they found no significant difference in the mice's memory ability at the end of the week, they did find that the tau protein was significantly increased in the group that received the corticosteroid.
"This was surprising because we didn't see any significant memory impairment, but the pathology for memory and learning impairment was definitely visible," said Pratico.
"So we believe we have identified the earliest type of damage that precedes memory deficit in Alzheimer's patients," he said.
Another surprising outcome was that a third group of mice that were genetically altered to be devoid of the brain enzyme 5-lipoxygenase appeared to be immune and showed no neuronal damage from the corticosteroid.
"The question has always been what up-regulates or increases 5-lipoxygenase, and now we have evidence that it is the stress hormone," he said.
"Corticosteroid uses the 5-lipoxygenase as a mechanism to damage the synapse, which results in memory and learning impairment, both key symptoms for Alzheimer's," he said.
The study was published in the journal Aging Cell.